SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-074970
Filing Date
2023-09-07
Accepted
2023-09-07 16:05:36
Documents
1
Period of Report
2023-09-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1547
  Complete submission text file 0001213900-23-074970.txt   2908
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALECTOR, INC 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Kenkare-Mitra Sara (Reporting) CIK: 0001895592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40582 | Film No.: 231242284